Reported Earnings • Aug 05
Second quarter 2026 earnings released: EPS: CN¥0.088 (vs CN¥0.034 in 2Q 2025) Second quarter 2026 results: EPS: CN¥0.088 (up from CN¥0.034 in 2Q 2025). Revenue: CN¥2.38b (up 37% from 2Q 2025). Net income: CN¥315.9m (up 153% from 2Q 2025). Profit margin: 13% (up from 7.2% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Tillkännagivande • Jun 30
Tinergy Chemical Co., Ltd. to Report First Half, 2026 Results on Aug 05, 2026 Tinergy Chemical Co., Ltd. announced that they will report first half, 2026 results on Aug 05, 2026 Tillkännagivande • Apr 29
Tinergy Chemical Co., Ltd., Annual General Meeting, May 20, 2026 Tinergy Chemical Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: 9F, Building 6, Yard No. 12, Anxiang Avenue, Shunyi District, Beijing China Tillkännagivande • Mar 31
Tinergy Chemical Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Tinergy Chemical Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Tillkännagivande • Dec 31
Tinergy Chemical Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026 Tinergy Chemical Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026 Tillkännagivande • Sep 30
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Q3, 2025 Results on Oct 28, 2025 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report Q3, 2025 results on Oct 28, 2025 Tillkännagivande • Sep 25
Wenzhou Yingsheng Industrial Co., Ltd. signed an agreement to acquire Hami Zhonghe Fantai Co., Ltd. from CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) for approximately CNY 120 million. Wenzhou Yingsheng Industrial Co., Ltd. signed an agreement to acquire Hami Zhonghe Fantai Co., Ltd. from CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) for approximately CNY 120 million on September 24, 2025. A cash consideration of CNY 120.8 million will be paid by Wenzhou Yingsheng Industrial Co., Ltd. Wenzhou Yingsheng Industrial Co., Ltd. has paid a total of CNY 30 million in security deposits, within 5 working days after the effectiveness of this Agreement, the Buyer shall pay CNY 0.2 million and within 90 days after the effectiveness of this Agreement, the Buyer shall directly remit the remaining Transfer Price of CNY 90.61 million to the settlement account designated by the Seller.
As of August 31, 2025, Hami Zhonghe Fantai Co., Ltd. reported total assets of CNY 123.13 million and total common equity of CNY 119.75 million.
The proposal was approved at the first meeting of the independent directors' special meeting of the eighth board of directors of CNNC Hua Yuan Titanium Dioxide Co., Ltd, and the independent directors voted unanimously to submit it to the board of directors for review. Tillkännagivande • Jul 02
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025 Tillkännagivande • Mar 31
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Q1, 2025 Results on Apr 30, 2025 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report Q1, 2025 results on Apr 30, 2025 Tillkännagivande • Mar 13
CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) announces an Equity Buyback for CNY 500 million worth of its shares. CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of its shares. The shares will be repurchased at CNY 6 per share. The purpose of the program is employee stock ownership plan or equity incentive. The program will be funded using own funds and self-raised funds (special repurchase loans from commercial banks). The program is valid for 12 months. Tillkännagivande • Mar 12
CNNC Hua Yuan Titanium Dioxide Co., Ltd Announces the Profit Distribution Proposal for 2024 CNNC Hua Yuan Titanium Dioxide Co. Ltd. announced on 11 March 2025 the profit distribution proposal for 2024 as follows: Cash dividend per 10 shares (tax included) of CNY 0.16000000. Tillkännagivande • Mar 11
CNNC Hua Yuan Titanium Dioxide Co., Ltd, Annual General Meeting, Apr 01, 2025 CNNC Hua Yuan Titanium Dioxide Co., Ltd, Annual General Meeting, Apr 01, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Tillkännagivande • Dec 31
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Fiscal Year 2024 Results on Mar 11, 2025 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report fiscal year 2024 results on Mar 11, 2025 New Risk • Oct 25
New major risk - Revenue and earnings growth Earnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.8% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥3.94, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 61% over the past three years. Tillkännagivande • Sep 30
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Q3, 2024 Results on Oct 25, 2024 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report Q3, 2024 results on Oct 25, 2024 Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥3.93, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years. Tillkännagivande • Aug 31
CNNC Hua Yuan Titanium Dioxide Co., Ltd Approves Board Elections CNNC Hua Yuan Titanium Dioxide Co. Ltd. at its Extraordinary General Meeting held on 29 August 2024 approved the election of Su Xiaohua, Zhang Longqing and Zheng Boquan as independent director. Tillkännagivande • Jun 29
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report First Half, 2024 Results on Aug 13, 2024 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report first half, 2024 results on Aug 13, 2024 Tillkännagivande • May 16
CNNC Hua Yuan Titanium Dioxide Co., Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 21 May 2024 CNNC Hua Yuan Titanium Dioxide Co. Ltd. announced 2023 final profit distribution plan to be implemented (A shares) cash dividend of CNY 0.50516800 /10 shares (tax included). Payment date: 21 May 2024. Record date: 20 May 2024. Ex-date: 21 May 2024. Tillkännagivande • Apr 19
CNNC Hua Yuan Titanium Dioxide Co., Ltd, Annual General Meeting, May 10, 2024 CNNC Hua Yuan Titanium Dioxide Co., Ltd, Annual General Meeting, May 10, 2024, at 14:00 China Standard Time. Location: 8F, Building D, Shuangchuang Base, Ma'anshan, Anhui China Reported Earnings • Apr 18
Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.22 in FY 2022) Full year 2023 results: EPS: CN¥0.12 (down from CN¥0.22 in FY 2022). Revenue: CN¥4.95b (down 9.8% from FY 2022). Net income: CN¥419.1m (down 35% from FY 2022). Profit margin: 8.5% (down from 12% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥3.59, the stock trades at a trailing P/E ratio of 40.8x. Average trailing P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 45% over the past three years. Tillkännagivande • Mar 30
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Q1, 2024 Results on Apr 18, 2024 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report Q1, 2024 results on Apr 18, 2024 Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥3.27, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 37% over the past three years. Tillkännagivande • Dec 29
CNNC Hua Yuan Titanium Dioxide Co., Ltd to Report Fiscal Year 2023 Results on Apr 18, 2024 CNNC Hua Yuan Titanium Dioxide Co., Ltd announced that they will report fiscal year 2023 results on Apr 18, 2024 Reported Earnings • Oct 20
Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.027 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.031 (up from CN¥0.027 in 3Q 2022). Revenue: CN¥1.38b (up 14% from 3Q 2022). Net income: CN¥119.9m (up 50% from 3Q 2022). Profit margin: 8.7% (up from 6.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Tillkännagivande • Sep 29
CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) announces an Equity Buyback for CNY 1,000 million worth of its shares. CNNC Hua Yuan Titanium Dioxide Co., Ltd (SZSE:002145) announces a share repurchase program. Under the program, the company will repurchase up to CNY 1,000 million worth of its shares. The program will be valid for 3 months. Valuation Update With 7 Day Price Move • Sep 20
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to CN¥4.75, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.028 (vs CN¥0.08 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.028 (down from CN¥0.08 in 2Q 2022). Revenue: CN¥981.7m (down 29% from 2Q 2022). Net income: CN¥109.7m (down 54% from 2Q 2022). Profit margin: 11% (down from 17% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 45% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jun 15
CNNC Hua Yuan Titanium Dioxide Co., Ltd Announces Final Dividend on A Shares for the Year 2022, Payable on June 20, 2023 CNNC Hua Yuan Titanium Dioxide Co. Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.50000000 on A shares for the year 2022. Record date is June 19, 2023. Ex-date is May June 20, 2023. Payment date is June 20, 2023. Tillkännagivande • May 20
CNNC Hua Yuan Titanium Dioxide Co., Ltd Approves Cash Dividend for the Year 2022 CNNC Hua Yuan Titanium Dioxide Co. Ltd. at its Annual General Meeting held on 18 May 2023, approved cash dividend/10 shares (tax included) of CNY 0.50000000 for the year 2022. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.032 (vs CN¥0.10 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.032 (down from CN¥0.10 in 1Q 2022). Revenue: CN¥1.23b (down 17% from 1Q 2022). Net income: CN¥104.5m (down 65% from 1Q 2022). Profit margin: 8.5% (down from 20% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Dec 26
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 15%. The fair value is estimated to be CN¥7.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 26%. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Shunmin Wang was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥0.027 (vs CN¥0.12 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.027 (down from CN¥0.12 in 3Q 2021). Revenue: CN¥1.21b (down 12% from 3Q 2021). Net income: CN¥79.8m (down 77% from 3Q 2021). Profit margin: 6.6% (down from 25% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Aug 28
Now 22% undervalued Over the last 90 days, the stock is up 13%. The fair value is estimated to be CN¥11.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 35%. Reported Earnings • Aug 27
Second quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.12 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.08 (down from CN¥0.12 in 2Q 2021). Revenue: CN¥1.39b (flat on 2Q 2021). Net income: CN¥236.5m (down 36% from 2Q 2021). Profit margin: 17% (down from 27% in 2Q 2021). Over the next year, revenue is forecast to grow 29%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥10.48, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 281% over the past three years. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥8.46, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 189% over the past three years. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥9.89, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 132% over the past three years. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.14 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.15 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.49b (up 21% from 1Q 2021). Net income: CN¥300.5m (up 4.6% from 1Q 2021). Profit margin: 20% (down from 23% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 63%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Non-Independent Director Yuehan Hu was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 23
Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.074 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.38b (up 28% from 3Q 2020). Net income: CN¥345.0m (up 211% from 3Q 2020). Profit margin: 25% (up from 10% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥13.54, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 286% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.16 per share. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥19.45, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 439% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥18.52 per share. Reported Earnings • Aug 28
Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.063 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.37b (up 69% from 2Q 2020). Net income: CN¥369.5m (up 345% from 2Q 2020). Profit margin: 27% (up from 10% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 74% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥19.80, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 409% over the past three years. Valuation Update With 7 Day Price Move • Jul 10
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥15.15, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 306% over the past three years. Reported Earnings • Apr 27
First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.10 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.24b (up 50% from 1Q 2020). Net income: CN¥287.2m (up 77% from 1Q 2020). Profit margin: 23% (up from 20% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 25
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥10.37, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 125% over the past three years. Reported Earnings • Apr 07
Full year 2020 earnings released: EPS CN¥0.27 (vs CN¥0.28 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥3.72b (up 10.0% from FY 2019). Net income: CN¥475.2m (up 10% from FY 2019). Profit margin: 13% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥9.02, the stock is trading at a trailing P/E ratio of 29.3x, up from the previous P/E ratio of 24.3x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 73%. Is New 90 Day High Low • Feb 11
New 90-day high: CN¥9.02 The company is up 45% from its price of CN¥6.20 on 13 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improved over the past week After last week's 27% share price gain to CN¥7.82, the stock is trading at a trailing P/E ratio of 25.4x, up from the previous P/E ratio of 20.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 51%. Is New 90 Day High Low • Jan 22
New 90-day high: CN¥6.80 The company is up 24% from its price of CN¥5.48 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥5.37 The company is down 2.0% from its price of CN¥5.49 on 30 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Is New 90 Day High Low • Nov 17
New 90-day high: CN¥6.64 The company is up 8.0% from its price of CN¥6.17 on 19 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. Valuation Update With 7 Day Price Move • Nov 17
Market bids up stock over the past week After last week's 17% share price gain to CN¥6.64, the stock is trading at a trailing P/E ratio of 20.8x, up from the previous P/E ratio of 17.8x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 14%. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥458.2m, up 9.6% from the prior year. Total revenue was CN¥3.53b over the last 12 months, up 6.6% from the prior year. 
